Our CEO Susan Greenfield and Operations Direction Sara Garcia-Rates, joined Xenopat for a face-to-face meeting in Barcelona where they shared the progress made for the Tecniospring Industry project “Development of a T14 Inhibitor for Treatment of ColoRectal Cancer”, and explored the possibilities for future projects that could sprout from this collaboration.
LATEST NEWS
- Neuro-Bio featured in the UK Ageing Network (UKAN) Newsletter – July 2024
- Neuro-Bio welcomes students from City of Oxford College
- Baroness Greenfield interview by Norman Swan – ABC Radio, Australia – May 2024!
- Baroness Greenfield speaks at the Early Career Researcher Retreat – June 2024
- Neuro-Bio is a finalist at the Thames Valley Tech & Innovation Awards 2024!